BRANDYWINE REALTY TRUST — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that BRANDYWINE REALTY TRUST filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $484.45M | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $505.52M | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | $514.65M | Feb 23, 2026 |
| FY2024 | Dec 31, 2022 | $506.10M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $486.82M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $534.85M | Feb 21, 2023 |
| FY2019 | Dec 31, 2019 | $147.04M | Mar 2, 2020 |
| FY2019 | Sep 30, 2019 | $145.33M | Mar 2, 2020 |
| FY2019 | Jun 30, 2019 | $144.15M | Mar 2, 2020 |
| FY2019 | Mar 31, 2019 | $143.90M | Mar 2, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $299.26M | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $318.19M | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | $324.70M | Feb 23, 2026 |
| FY2024 | Dec 31, 2022 | $311.70M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $298.51M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $329.40M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $354.57M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $326.25M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $314.42M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $316.02M | Feb 22, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($178.25M) | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | ($195.91M) | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | ($196.79M) | Feb 23, 2026 |
| FY2024 | Dec 31, 2022 | $53.82M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $12.29M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $305.53M | Feb 21, 2023 |
| FY2019 | Dec 31, 2019 | $16.68M | Mar 2, 2020 |
| FY2019 | Sep 30, 2019 | $6.68M | Mar 2, 2020 |
| FY2019 | Jun 30, 2019 | $6.11M | Mar 2, 2020 |
| FY2019 | Mar 31, 2019 | $4.40M | Mar 2, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $26.66M | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $54.88M | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | ($21.58M) | Feb 23, 2026 |
| FY2024 | Dec 31, 2022 | $119.73M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $93.30M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $400.49M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $114.79M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $56.71M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $135.47M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $185.44M | Feb 22, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $116.70M | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $181.13M | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | $177.27M | Feb 23, 2026 |
| FY2024 | Dec 31, 2022 | $209.31M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $190.87M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $225.81M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $234.23M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $227.35M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $182.58M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $173.80M | Feb 22, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.59B | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $3.49B | Feb 23, 2026 |
| FY2024 | Dec 31, 2023 | $3.73B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $3.87B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $3.85B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $3.90B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $4.08B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $4.08B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $4.00B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $4.10B | Feb 23, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.79B | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $2.45B | Feb 23, 2026 |
| FY2024 | Dec 31, 2023 | $2.41B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $2.24B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $2.14B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $2.10B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $2.39B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $2.27B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $2.15B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $2.22B | Feb 23, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $792.73M | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $1.04B | Feb 23, 2026 |
| FY2024 | Dec 31, 2023 | $1.32B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $1.63B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $1.69B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $1.79B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $1.68B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $1.80B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $1.83B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $1.87B | Feb 23, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | $499.09M | Feb 29, 2016 |
| FY2015 | Dec 31, 2014 | $529.49M | Feb 29, 2016 |
| FY2014 | Dec 31, 2013 | $522.53M | Feb 19, 2015 |
| FY2013 | Dec 31, 2012 | $479.73M | Feb 25, 2014 |
| FY2012 | Dec 31, 2011 | $477.34M | Feb 26, 2013 |
| FY2011 | Dec 31, 2010 | $483.44M | Feb 24, 2012 |
| FY2010 | Dec 31, 2009 | $501.38M | Feb 25, 2011 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $32.28M | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $90.23M | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | $58.32M | Feb 23, 2026 |
| FY2025 | Dec 31, 2022 | $17.55M | Feb 23, 2026 |
| FY2024 | Dec 31, 2021 | $27.46M | Feb 27, 2025 |
| FY2023 | Dec 31, 2020 | $46.34M | Feb 22, 2024 |
| FY2022 | Dec 31, 2019 | $90.50M | Feb 21, 2023 |
| FY2021 | Dec 31, 2018 | $22.84M | Feb 24, 2022 |
| FY2020 | Dec 31, 2017 | $202.18M | Feb 24, 2021 |
| FY2019 | Dec 31, 2016 | $193.92M | Mar 2, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.56B | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $2.21B | Feb 23, 2026 |
| FY2023 | Dec 31, 2023 | $2.14B | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | $1.83B | Feb 24, 2021 |
| FY2020 | Dec 31, 2019 | $2.14B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $2.03B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $1.93B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $2.01B | Feb 23, 2018 |
| FY2016 | Dec 31, 2015 | $2.38B | Mar 1, 2017 |
| FY2015 | Dec 31, 2014 | $2.43B | Feb 29, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Feb 23, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 21, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Mar 2, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Feb 23, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 21, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Mar 2, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 173.70M | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | 172.67M | Feb 23, 2026 |
| FY2020 | Dec 31, 2020 | 170.57M | Feb 24, 2021 |
| FY2020 | Dec 31, 2019 | 176.48M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | 176.87M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | 178.29M | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | 175.14M | Feb 23, 2018 |
| FY2016 | Dec 31, 2015 | 174.69M | Mar 1, 2017 |
| FY2015 | Dec 31, 2014 | 179.29M | Feb 29, 2016 |
| FY2014 | Dec 31, 2013 | 156.73M | Feb 19, 2015 |